Abstract
Aspergillus lentulus has been recognized within Aspergillus section Fumigati as a phenotypically similar but genetically distinct species, displaying reduced susceptibility to antifungal agents. It has been described as a cause of invasive aspergillosis in patients who underwent hematopoietic stem cell transplantation, solid organ transplant recipients, those on prolonged corticosteroid therapy, or in patients with structural lung disease including chronic obstructive pulmonary disease. We report a case of successful treatment of probable invasive pulmonary aspergillosis due to A. lentulus and polymicrobial infection with Pseudomonas aeruginosa in a patient with relapsing granulomatosis with polyangiitis and recent high-dose steroid therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 100-105 |
Number of pages | 6 |
Journal | Infectious Diseases in Clinical Practice |
Volume | 26 |
Issue number | 2 |
DOIs | |
State | Published - 2018 |
Keywords
- Aspergillus lentulus
- Invasive fungal infection
- Lung abscess
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases